166 related articles for article (PubMed ID: 38434523)
1. On behalf of the SFGM-TC: Real-life use of third-party virus-specific T-cell transfer in immunocompromised transplanted patients.
Leroyer EH; Petitpain N; Morisset S; Neven B; Castelle M; Winter S; Souchet L; Morel V; Le Cann M; Fahd M; Yacouben K; Mechinaud F; Ouachée-Chardin M; Renard C; Wallet HL; Angoso M; Jubert C; Chevallier P; Léger A; Rialland F; Dhedin N; Robin C; Maury S; Beckerich F; Beauvais D; Cluzeau T; Loschi M; Fernster A; Bittencourt MC; Cravat M; Bilger K; Clément L; Decot V; Gauthier M; Legendre A; Larghero J; Ouedrani A; Martin-Blondel G; Pochon C; Reppel L; Rouard H; Nguyen-Quoc S; Dalle JH; D'Aveni M; Bensoussan D
Hemasphere; 2024 Jan; 8(1):e40. PubMed ID: 38434523
[No Abstract] [Full Text] [Related]
2. [Sexual and emotional life after allogeneic hematopoietic stem cell transplant: Guidelines and patient booklet from the Francophone Society of Bone marrow Transplant and Cellular therapy (SFGM-TC)].
Alsuliman T; Baylet C; Casabona A; Dann MP; De Bentzmann N; Fontoura ML; Genty C; Huynh A; Ibled D; Mercier L; Poirot C; Porcheron S; Tourette-Turgis C; Vernant JP; Vexiau-Robert D; Yakoub-Agha I; Nguyen S
Bull Cancer; 2020 Dec; 107(12S):S151-S158. PubMed ID: 32747052
[TBL] [Abstract][Full Text] [Related]
3. Transfer of minimally manipulated CMV-specific T cells from stem cell or third-party donors to treat CMV infection after allo-HSCT.
Neuenhahn M; Albrecht J; Odendahl M; Schlott F; Dössinger G; Schiemann M; Lakshmipathi S; Martin K; Bunjes D; Harsdorf S; Weissinger EM; Menzel H; Verbeek M; Uharek L; Kröger N; Wagner E; Kobbe G; Schroeder T; Schmitt M; Held G; Herr W; Germeroth L; Bonig H; Tonn T; Einsele H; Busch DH; Grigoleit GU
Leukemia; 2017 Oct; 31(10):2161-2171. PubMed ID: 28090089
[TBL] [Abstract][Full Text] [Related]
4. Curative or pre-emptive adenovirus-specific T cell transfer from matched unrelated or third party haploidentical donors after HSCT, including UCB transplantations: a successful phase I/II multicenter clinical trial.
Qian C; Campidelli A; Wang Y; Cai H; Venard V; Jeulin H; Dalle JH; Pochon C; D'aveni M; Bruno B; Paillard C; Vigouroux S; Jubert C; Ceballos P; Marie-Cardine A; Galambrun C; Cholle C; Clerc Urmes I; Petitpain N; De Carvalho Bittencourt M; Decot V; Reppel L; Salmon A; Clement L; Bensoussan D
J Hematol Oncol; 2017 May; 10(1):102. PubMed ID: 28482908
[TBL] [Abstract][Full Text] [Related]
5. Comparison of umbilical cord blood allogeneic stem cell transplantation vs. auto-SCT for adult acute myeloid leukemia patients in second complete remission at transplant: a retrospective study on behalf of the SFGM-TC.
Chevallier P; Labopin M; Socie G; Rubio MT; Blaise D; Vigouroux S; Huynh A; Michallet M; Bay JO; Maury S; Yakoub-Agha I; Fegueux N; Deconinck E; Contentin N; Maillard N; Bulabois CE; Francois S; Oumedaly R; Raus N; Mohty M
Eur J Haematol; 2015 May; 94(5):449-55. PubMed ID: 25238651
[TBL] [Abstract][Full Text] [Related]
6. [How we harmonize HSCT clinical practices among the SFGM-TC centers].
Tipton R; Yakoub-Agha I
Bull Cancer; 2016 Nov; 103(11S):S193-S197. PubMed ID: 27810144
[TBL] [Abstract][Full Text] [Related]
7. [Prevention and management of infections in patients undergoing CAR T-cell therapy: Recommendations of the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)].
Paul F; Vicente C; Courbon C; Moreau AS; Picard M; Pochon C; Sterin A; Tudesq JJ; Yakoub-Agha M; Bay JO; Yakoub-Agha I
Bull Cancer; 2021 Dec; 108(12S):S90-S97. PubMed ID: 34876272
[TBL] [Abstract][Full Text] [Related]
8. Off-the-Shelf Third-Party Virus-Specific T Cell Therapy to Treat JC Polyomavirus Infection in Hematopoietic Stem Cell Transplantation Recipients.
Rubinstein JD; Jodele S; Heyenbruch D; Wilhelm J; Thomas S; Lutzko C; Zhu X; Leemhuis T; Cancelas JA; Keller M; Bollard CM; Hanley PJ; Boghdadly ZE; Mims A; Davies SM; Grimley MS; Nelson AS
Transplant Cell Ther; 2022 Feb; 28(2):116.e1-116.e7. PubMed ID: 34785398
[TBL] [Abstract][Full Text] [Related]
9. Impact of COVID-19 pandemic on the use and release of cord blood units facilitated by the French Cord Blood Banks Network: on behalf of the Agency of Biomedicine, Eurocord and the French Society of Bone Marrow Transplant and Cell Therapy (SFGM-TC).
Rafii H; Ionescu I; Ruggeri A; Garnier F; Ballot C; Bensoussan D; Chabannon C; Dazey B; De Vos J; Gautier E; Giraud C; Larghero J; Cras A; Mialou V; Persoons V; Pouthier F; Thibert JB; Dalle JH; Michel G; Sinayoko M; Kenzey C; Volt F; Rocha V; Bay JO; Rubio MT; Robin M; Faucher C; Marry E; Gluckman E
Bone Marrow Transplant; 2022 Jan; 57(1):125-127. PubMed ID: 34621021
[No Abstract] [Full Text] [Related]
10. [Transfer of allogeneic stem cell transplant recipients to the intensive care unit: Guidelines from the Francophone society of marrow transplantation and cellular therapy (SFGM-TC)].
Moreau AS; Bourhis JH; Contentin N; Couturier MA; Delage J; Dumesnil C; Gandemer V; Hichri Y; Jost E; Platon L; Jourdain M; Pène F; Yakoub-Agha I
Bull Cancer; 2016 Nov; 103(11S):S220-S228. PubMed ID: 27816169
[TBL] [Abstract][Full Text] [Related]
11. [Diagnosis and treatment of CMV and EBV Reactivation as well as Post-transplant Lymphoproliferative Disorders following Allogeneic Stem Cell Transplantation: An SFGM-TC report].
Bay JO; Peffault de Latour R; Bruno B; Coiteux V; Guillaume T; Hicheri Y; Paillard C; Suarez F; Turlure P; Alain S; Bulabois CE; Socié G; Bauters F; Yakoub-Agha I;
Pathol Biol (Paris); 2013 Aug; 61(4):152-4. PubMed ID: 24011961
[TBL] [Abstract][Full Text] [Related]
12. Sexual and Emotional Health after Allogeneic Hematopoietic Cell Transplantation: A Comprehensive Review and Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC).
Alsuliman T; Jondreville L; Baylet C; Dann MP; De Bentzmann N; Fontoura ML; Genty C; Huynh A; Ibled D; Yakoub-Agha I; Mercier L; Poirot C; Porcheron S; Tourette-Turgis C; Vernant JP; Vexiau-Robert D; Nguyen S
J Clin Med; 2022 Feb; 11(5):. PubMed ID: 35268291
[TBL] [Abstract][Full Text] [Related]
13. Ruxolitinib before allogeneic hematopoietic transplantation in patients with myelofibrosis on behalf SFGM-TC and FIM groups.
Robin M; Porcher R; Orvain C; Bay JO; Barraco F; Huynh A; Charbonnier A; Forcade E; Chantepie S; Bulabois C; Yakoub-Agha I; Detrait M; Michonneau D; Turlure P; Raus N; Boyer F; Suarez F; Vincent L; Guyen SN; Cornillon J; Villate A; Dupriez B; Cassinat B; Rolland V; Schlageter MH; Socié G; Kiladjian JJ
Bone Marrow Transplant; 2021 Aug; 56(8):1888-1899. PubMed ID: 33767402
[TBL] [Abstract][Full Text] [Related]
14. A cost-effective strategy for selection of third-party donors for a virus-specific T-cell bank for an Asian patient population.
Linn YC; Sundar Raj K; Teo B; Phang CY; Chittezhath M; Koh M
Cytotherapy; 2023 May; 25(5):510-520. PubMed ID: 36882347
[TBL] [Abstract][Full Text] [Related]
15. Familial CD45RA
Al-Akioui Sanz K; Echecopar Parente C; Ferreras C; Menéndez Ribes M; Navarro A; Mestre C; Clares L; Vicario JL; Balas A; De Paz R; López Granados E; Sánchez Zapardiel E; Jiménez C; López-Oliva M; Ramos E; Hernández-Oliveros F; Pérez-Martínez A
Front Med (Lausanne); 2023; 10():1083215. PubMed ID: 36844219
[TBL] [Abstract][Full Text] [Related]
16. Brentuximab vedotin as a bridge to allogeneic stem-cell transplantation for refractory or relapsing patients with CD30 positive anaplastic or T-cell non-Hodgkin lymphomas: a study on behalf of the SFGM-TC.
Garciaz S; Loschi M; De Masson A; Biard L; Mercier M; Tomowiak C; Delage J; Labussiere-Wallet H; Sibon D; Cassuto O; Borel C; Cornillon J; Nimubona S; Charbonnier A; Brice P; Socié G; Bouabdallah R; de Latour RP; de Fontbrune FS
Leuk Lymphoma; 2019 Nov; 60(11):2802-2805. PubMed ID: 31014144
[No Abstract] [Full Text] [Related]
17. [Management of neurotoxicity following CAR-T cell therapy: Recommendations of the SFGM-TC].
Picard M; Sterin A; Bay JO; Courbon C; Moreau AS; Paul F; Pochon C; Tudesq JJ; Vicente C; Yakoub-Agha M; Yakoub-Agha I
Bull Cancer; 2023 Feb; 110(2S):S123-S131. PubMed ID: 35094839
[TBL] [Abstract][Full Text] [Related]
18. [Medium-term follow-up of patients treated with chimeric antigen receptor T cells (CAR T cells): Recommendations of the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)].
Alsuliman T; Drieu La Rochelle L; Campidelli A; Duléry R; Fayard A; Mamez AC; Mear JB; Schneider PO; Trevet A; Vicente C; Yakoub-Agha I
Bull Cancer; 2021 Dec; 108(12S):S65-S71. PubMed ID: 33678408
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of haematopoietic stem cell boost as a rescue for poor graft function after haematopoietic stem cell transplantation: A multicentre retrospective study on behalf of the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC).
Gaffet M; Wiedemann A; Dalle JH; Bilger K; Forcade E; Robin M; Cornillon J; Labussière-Wallet H; Ceballos P; Bulabois CE; Loschi M; Orvain C; Rubio MT; Neven B; Pagliuca S; Pochon C
Br J Haematol; 2023 Jun; 201(6):1153-1158. PubMed ID: 36974355
[TBL] [Abstract][Full Text] [Related]
20. Adoptive T-cell immunotherapy from third-party donors: characterization of donors and set up of a T-cell donor registry.
Eiz-Vesper B; Maecker-Kolhoff B; Blasczyk R
Front Immunol; 2012; 3():410. PubMed ID: 23372567
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
